RIL
NTLA icon

Rothschild Investment LLC’s Intellia Therapeutics NTLA Stock Holding History

Rothschild Investment LLC’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57K Sell
329
-60
-15% -$840 ﹤0.01% 2212
2026
Q1 		$4.99K Buy
389
+258
+197% +$3.29K ﹤0.01% 2050
2025
Q4 		$1.18K Sell
131
-59
-31% -$812 ﹤0.01% 2612
2025
Q3 		$3.28K Sell
190
-50
-21% -$616 ﹤0.01% 1928
2025
Q2 		$2.25K Buy
240
+85
+55% +$698 ﹤0.01% 1993
2025
Q1 		$1.1K Buy
155
+40
+35% +$404 ﹤0.01% 2284
2024
Q4 		$1.34K Buy
115
+25
+28% +$390 ﹤0.01% 2044
2024
Q3 		$1.85K Buy
90
+50
+125% +$1.15K ﹤0.01% 1772
2024
Q2 		$895 Buy
40
+30
+300% +$714 ﹤0.01% 1717
2024
Q1 		$275 Buy
+10
New +$278 ﹤0.01% 1600

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Rothschild Investment LLC's NTLA Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Intellia Therapeutics (NTLA) stake by 15% in Q2 2026, selling an estimated $840 and leaving 329 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2212.

Rothschild Investment LLC first reported a position in NTLA in Q1 2024 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Rothschild Investment LLC held 329 shares of Intellia Therapeutics worth $5.57K as of Q2 2026.
  • Rothschild Investment LLC sold 60 Intellia Therapeutics shares in Q2 2026, an estimated $840.
  • Intellia Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2212 holding.
  • Rothschild Investment LLC first reported a position in Intellia Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 327 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.